Skip Navigation

Cardiovascular Research 1998 40(1):191-205; doi:10.1016/S0008-6363(98)00141-2
© 1998 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Bobryshev, Y. V.
Right arrow Articles by Ikezawa, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bobryshev, Y. V.
Right arrow Articles by Ikezawa, T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 1998, European Society of Cardiology

The cell adhesion molecule E-cadherin is widely expressed in human atherosclerotic lesions

Yuri V. Bobrysheva,b,*, Reginald S.A. Lorda, Teruo Watanabec and Tsuyoshi Ikezawac

aSurgical Professorial Unit, St. Vincent's Hospital, Darlinghurst NSW 2010, Australia
bSchool of Anatomy, University of New South Wales, Sydney NSW 2052, Australia
cDepartment of Pathology, Institute of Basic Medical Sciences, University of Tsukuba, Tsukuba 305, Japan

* Corresponding author. Tel.: +61-2-9-3612354; fax: +61-2-9-3604424.

Objective: Various cell adhesion molecules are expressed in atherogenesis and the significance of their involvement in atherosclerotic lesion formation is well appreciated. In the present work, we examined whether the Ca2+-dependent cell adhesion molecule E-cadherin is also involved in atherogenesis. Methods: Specimens of carotid artery and aorta were obtained at operation. Expression of E-cadherin was studied by an immunohistochemical method. The nature of E-cadherin-expressing cells was examined by comparative analysis of consecutive sections and by a double immunostaining procedure. An immunohistochemical approach was also applied to examine how the accumulation of oxidised low density lipoproteins (LDL) by intimal cells is associated with E-cadherin expression. Results: No E-cadherin+ cells were found in normal non-atherosclerotic intima but E-cadherin+ cells were present in 96% of the atherosclerotic lesions. In atherosclerotic intima, E-cadherin was expressed by intimal cells showing varying degrees of transformation into foam cells. These E-cadherin+ cells also contained oxidised LDL in their cytoplasm. Differing numbers of CD68+ foam cells (15% to 60%) expressed E-cadherin but all the CD68+ macrophages without signs of transformation into foam cells were negative for E-cadherin. Neither smooth muscle cells nor foam cells of smooth muscle cell origin (smooth muscle alpha-actin+) were found to be positive for E-cadherin. T-cells (CD3+) and endothelial cells (von Willebrand factor+) were also negative for E-cadherin. Only a few vascular dendritic cells (S-100+) expressed E-cadherin and their expression was weak. We also found that a large proportion (40% to 85%) of E-cadherin+ cells did not stain with any cell-type specific markers. Conclusions: The finding that E-cadherin is expressed in atherosclerotic lesions expands our knowledge of cell adhesion molecules involved in atherogenesis. That E-cadherin is expressed in intimal cells transforming into foam cells suggests that lipid accumulation might be associated with the alteration and reorganisation of cell-to-cell interactions in atherogenesis. The present observations might assist in understanding the mechanisms associated with intracellular lipid accumulation.

KEYWORDS Arteries; Atherosclerosis; Cell adhesion molecules; E-cadherin; Foam cells; Dendritic cells


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
CarcinogenesisHome page
T. P. Ellen, Q. Ke, P. Zhang, and M. Costa
NDRG1, a growth and cancer related gene: regulation of gene expression and function in normal and disease states
Carcinogenesis, January 1, 2008; 29(1): 2 - 8.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
K. P. Burdon, J. L. Bento, C. D. Langefeld, J. K. Campbell, J. J. Carr, L. M. Wagenknecht, D. M. Herrington, B. I. Freedman, S. S. Rich, and D. W. Bowden
Association of Protein Tyrosine Phosphatase-N1 Polymorphisms With Coronary Calcified Plaque in the Diabetes Heart Study
Diabetes, March 1, 2006; 55(3): 651 - 658.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. Blindt, A.-K. Bosserhoff, J. Dammers, N. Krott, L. Demircan, R. Hoffmann, P. Hanrath, C. Weber, and F. Vogt
Downregulation of N-cadherin in the neointima stimulates migration of smooth muscle cells by RhoA deactivation
Cardiovasc Res, April 1, 2004; 62(1): 212 - 222.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
E. P. Moiseeva
Adhesion receptors of vascular smooth muscle cells and their functions
Cardiovasc Res, December 1, 2001; 52(3): 372 - 386.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
Y. V. Bobryshev and R. S.A. Lord
55-kD Actin-bundling Protein (p55) Is a Specific Marker for Identifying Vascular Dendritic Cells
J. Histochem. Cytochem., November 1, 1999; 47(11): 1481 - 1486.
[Abstract] [Full Text]


Home page
Cardiovasc ResHome page
Y. V Bobryshev, S. M Cherian, S. J Inder, and R. S.A Lord
Neovascular expression of VE-cadherin in human atherosclerotic arteries and its relation to intimal inflammation
Cardiovasc Res, September 1, 1999; 43(4): 1003 - 1017.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.